Skip to content

Inhibitor Therapeutics, Inc.

Public company
Headquarters
TAMPA, Florida
Ticker
INTI
CIK
0001042418

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

6
6 appointments, 0 departures

Last event

Sep 18, 2026
Executive appointmentDirector appointed: Francis E. O’Donnell

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
DirectorFrancis E. O’DonnellSep 18, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    Director appointed: Francis E. O’Donnell

    Francis E. O’Donnell was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

  2. Executive appointment

    Director appointed: Samuel J. Sears

    Samuel J. Sears was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

  3. Executive appointment

    Director appointed: Niraj Vasisht

    Niraj Vasisht was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

  4. Executive appointment

    Director appointed: Michelle Yanez

    Michelle Yanez was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

  5. Executive appointment

    Director appointed: Michael Jerman

    Michael Jerman was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

  6. Executive appointment

    Director appointed: Ronald E. Osman

    Ronald E. Osman was named Director of Inhibitor Therapeutics, Inc., effective September 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Sep 18, 2026

Last verified Nov 8, 2026